Skip to main content
HRES 1285 117th Congress House Foreign Trade and International Finance Asia Cardiovascular and respiratory health China Congressional oversight Congressional-executive branch relations Emergency medical services and trauma care Free trade and trade barriers Government information and archives Health technology, devices, supplies Immunology and vaccination Infectious and parasitic diseases Intellectual property Presidents and presidential powers, Vice Presidents Trade agreements and negotiations World health

Requesting the President to transmit certain information to the House of Representatives relating to a waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights.

Introduced: July 26, 2022 Introduced by: Smith, Adrian Republican · Nebraska See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 8 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 28, 2022
Placed on the House Calendar, Calendar No. 127.
Sep 28, 2022
Reported adversely by the Committee on Ways and Means. H. Rept. 117-520.
Sep 20, 2022
Ordered to be Reported Adversely by Voice Vote.
Sep 20, 2022
Committee Consideration and Mark-up Session Held.
Sep 19, 2022
Subcommittee on Trade Discharged.
Jul 26, 2022
Referred to the Subcommittee on Trade.
Jul 26, 2022
Referred to the House Committee on Ways and Means.
Jul 26, 2022
Introduced in House
 Plain-English summary Congressional Research Service

This resolution requests that the President transmit certain information to the House of Representatives related to the June 17, 2022, waiver of intellectual property commitments under the World Trade Organization Agreement on Trade-Related Aspects of Intellectual Property Rights (known as the TRIPS waiver) and the proposed expansion of the TRIPS waiver.

In particular, the resolution requests information demonstrating that

  • the TRIPS waiver will increase global supply and delivery of COVID-19 vaccines and the extent to which these vaccines have been destroyed due to their expiration;
  • the proposed TRIPS waiver expansion will increase global supply and delivery of COVID-19 diagnostics or therapeutics;
  • the TRIPS waiver or the proposed TRIPS waiver expansion will accelerate the end of the COVID-19 pandemic; and
  • China will not obtain access to patents or other intellectual property related to COVID-19 vaccines, diagnostics, or therapeutics even if expressly excluded from the TRIPS waiver or the proposed TRIPS waiver expansion.
What's happening now September 28, 2022

Placed on the House Calendar, Calendar No. 127.

 Committees of jurisdiction 2